Bulk Manufacturer of Controlled Substances Application: Synthcon LLC, 11330-11333 [2021-03758]

Download as PDF 11330 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Controlled substance Drug code Codeine ........................................................................................................................................................................... Ecgonine .......................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Methadone ....................................................................................................................................................................... Morphine .......................................................................................................................................................................... Thebaine .......................................................................................................................................................................... Levo-Alphacetylmethadol (LAAM) ................................................................................................................................... Noroxymorphone ............................................................................................................................................................. Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... The company plans to manufacture reference standards. William T. McDermott, Assistant Administrator. [FR Doc. 2021–03760 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–796] Bulk Manufacturer of Controlled Substances Application: Bulk Manufacturer of Marihuana: Livwell Michigan, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW 8701 Morrissette Drive, Springfield, Virginia 22152. To ensure proper handling of comments, please reference Docket No. DEA–796 in all correspondence, including attachments. SUPPLEMENTARY INFORMATION: The Controlled Substances Act (CSA) prohibits the cultivation and khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 distribution of marihuana except by persons who are registered under the CSA to do so for lawful purposes. In accordance with the purposes specified in 21 CFR 1301.33(a), DEA is providing notice that the entity identified below has applied for registration as a bulk manufacturer of schedule I controlled substances. In response, registered bulk manufacturers of the affected basic class(es), and applicants therefor, may file written comments on or objections of the requested registration, as provided in this notice. This notice does not constitute any evaluation or determination of the merits of the application submitted. The applicant plans to manufacture bulk active pharmaceutical ingredients (APIs) for product development and distribution to DEA-registered researchers. If the application for registration is granted, the registrant would not be authorized to conduct other activity under this registration aside from those coincident activities specifically authorized by DEA regulations. DEA will evaluate the application for registration as a bulk manufacturer for compliance with all applicable laws, treaties, and regulations and to ensure adequate safeguards against diversion are in place. As this applicant has applied to become registered as a bulk manufacturer of marihuana, the application will be evaluated under the criteria of 21 U.S.C. 823(a). DEA will conduct this evaluation in the manner described in the rule published at 85 FR 82333 on December 18, 2020, and reflected in DEA regulations at 21 CFR part 1318. In accordance with 21 CFR 1301.33(a), DEA is providing notice that on January 25, 2021, Livwell Michigan, LLC, 21550 Hoover Road, Warren, Michigan 48089, applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances: PO 00000 Frm 00114 Fmt 4703 Sfmt 4703 Controlled substance Marihuana Extract ................... Marihuana ............................... Tetrahydrocannabinols ........... 9050 9180 9220 9230 9250 9300 9333 9648 9668 9739 9740 9743 9801 Schedule II II II II II II II II II II II II II Drug code 7350 7360 7370 Schedule I I I William T. McDermott, Assistant Administrator. [FR Doc. 2021–03759 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–792] Bulk Manufacturer of Controlled Substances Application: Synthcon LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. AGENCY: Synthcon LLC, has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before April 26, 2021. Such persons may also file a written request for a hearing on the application on or before April 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this is notice that on January 5, 2021, Synthcon LLC., 770 Wooten Road, Suite 101, Colorado Springs, Colorado 80915– 3538, applied to be registered as a bulk SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1 11331 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices manufacturer of the following basic class(es) of controlled substance(s): khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code 3-FMC .............................................................................................................................................................................. Cathinone ........................................................................................................................................................................ Methcathinone ................................................................................................................................................................. 4-FMC .............................................................................................................................................................................. Pentedrone ...................................................................................................................................................................... Mephedrone (4-Methyl-N-methylcathinone) .................................................................................................................... 4-MEC .............................................................................................................................................................................. Naphyrone ....................................................................................................................................................................... N-Ethylamphetamine ....................................................................................................................................................... N,N-Dimethylamphetamine .............................................................................................................................................. Aminorex .......................................................................................................................................................................... Cis-4-Methylaminorex ...................................................................................................................................................... GHB ................................................................................................................................................................................. Methaqualone .................................................................................................................................................................. Mecloqualone .................................................................................................................................................................. JWH-250 .......................................................................................................................................................................... ADB-PINACA ................................................................................................................................................................... JWH-018 .......................................................................................................................................................................... JWH-073 .......................................................................................................................................................................... JWH-200 .......................................................................................................................................................................... JWH-203 .......................................................................................................................................................................... 4-Methyl-alpha-ethylaminopentiophenone ....................................................................................................................... N-Ethyhexedrone ............................................................................................................................................................. AET .................................................................................................................................................................................. Ibogaine ........................................................................................................................................................................... CP-47,497 ........................................................................................................................................................................ CP-47,497 C8 HOMOLOG .............................................................................................................................................. LSD .................................................................................................................................................................................. 2C-T-7 .............................................................................................................................................................................. Tetrahydrocannabinols .................................................................................................................................................... Mescaline ......................................................................................................................................................................... 2C-T-2 .............................................................................................................................................................................. 3,4,5-TMA ........................................................................................................................................................................ DOB ................................................................................................................................................................................. 2CB .................................................................................................................................................................................. DOM ................................................................................................................................................................................ 2,5-DMA ........................................................................................................................................................................... JWH-398 .......................................................................................................................................................................... DOE ................................................................................................................................................................................. MDA ................................................................................................................................................................................. 5-METHOXY-MDA ........................................................................................................................................................... N-HYDROXY-MDA .......................................................................................................................................................... MDEA .............................................................................................................................................................................. MDMA .............................................................................................................................................................................. PMA ................................................................................................................................................................................. 5-MeO-DMT ..................................................................................................................................................................... AMT ................................................................................................................................................................................. Bufotenine ........................................................................................................................................................................ DET .................................................................................................................................................................................. DMT ................................................................................................................................................................................. Psilocybin ......................................................................................................................................................................... Psilocin ............................................................................................................................................................................ 5-Methoxy-N,N-diisopropyltryptamine ............................................................................................................................. 4-Methyl-alpha-pyrrolidinohexiophenone ......................................................................................................................... PCE ................................................................................................................................................................................. PCPy ................................................................................................................................................................................ TCP .................................................................................................................................................................................. TCPy ................................................................................................................................................................................ JB323 ............................................................................................................................................................................... JB336 ............................................................................................................................................................................... BZP .................................................................................................................................................................................. 4-MePPP ......................................................................................................................................................................... 2C-D ................................................................................................................................................................................ 2C-E ................................................................................................................................................................................. 2C-H ................................................................................................................................................................................ 2C-I .................................................................................................................................................................................. 2C-C ................................................................................................................................................................................ 2C-N ................................................................................................................................................................................ 2C-P ................................................................................................................................................................................. 2C-T-4 .............................................................................................................................................................................. MDPV .............................................................................................................................................................................. VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 1233 1235 1237 1238 1246 1248 1249 1258 1475 1480 1585 1590 2010 2565 2572 6250 7035 7118 7173 7200 7203 7245 7246 7249 7260 7297 7298 7315 7348 7370 7381 7385 7390 7391 7392 7395 7396 7398 7399 7400 7401 7402 7404 7405 7411 7431 7432 7433 7434 7435 7437 7438 7439 7446 7455 7458 7470 7473 7482 7484 7493 7498 7508 7509 7517 7518 7519 7521 7524 7532 7535 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I 11332 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices khammond on DSKJM1Z7X2PROD with NOTICES Controlled substance Drug code 25B-NBOME .................................................................................................................................................................... 25C-NBOME .................................................................................................................................................................... 25I-NBOME ..................................................................................................................................................................... Methylone ........................................................................................................................................................................ Butylone ........................................................................................................................................................................... Pentylone ......................................................................................................................................................................... N-Ethylpentyloe ............................................................................................................................................................... Alpha-Pyrrolidinohexanophenone .................................................................................................................................... Alpha-PVP ....................................................................................................................................................................... Alpha-PBP ....................................................................................................................................................................... Ethylone ........................................................................................................................................................................... AM-694 ............................................................................................................................................................................ Pseudoephedrine ............................................................................................................................................................. Ephedrine ........................................................................................................................................................................ Heroin .............................................................................................................................................................................. Normorphine .................................................................................................................................................................... Acetorphine ...................................................................................................................................................................... U-47700 ........................................................................................................................................................................... AH-7921 ........................................................................................................................................................................... MT-45 .............................................................................................................................................................................. Acetylmethadol ................................................................................................................................................................ Allylprodine ...................................................................................................................................................................... Alphacetylmethadol ......................................................................................................................................................... Alphameprodine ............................................................................................................................................................... Alphamethadol ................................................................................................................................................................. Benzethidine .................................................................................................................................................................... Betacetylmethadol ........................................................................................................................................................... Clonitazine ....................................................................................................................................................................... Isontonitazene ................................................................................................................................................................. Diampromide ................................................................................................................................................................... Diethylthiambutene .......................................................................................................................................................... Dimethylthiambutene ....................................................................................................................................................... Etonitazene ...................................................................................................................................................................... Ketobemidone .................................................................................................................................................................. MPPP ............................................................................................................................................................................... PEPAP ............................................................................................................................................................................. Tilidine ............................................................................................................................................................................. Acryl Fentanyl .................................................................................................................................................................. Para-fluorofentanyl .......................................................................................................................................................... 3-Methylfentanyl .............................................................................................................................................................. Alpha-methylfentanyl ....................................................................................................................................................... Acetyl-alpha-methylfentanyl ............................................................................................................................................. Ortho-fluorofentanyl ......................................................................................................................................................... Acetylfentanyl .................................................................................................................................................................. Butyrylfentanyl ................................................................................................................................................................. Para-fluorofentanyl .......................................................................................................................................................... Methoxyacetyl fentanyl .................................................................................................................................................... 4-Fluoroisobutyryl fentanyl (N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide) ......................................... Para-chloroisobutyryl fentanyl ......................................................................................................................................... Isobutyrylfentanyl ............................................................................................................................................................. Beta-Hydroxyfentanyl ...................................................................................................................................................... Beta-Hydroxy-3-methylfentanyl ....................................................................................................................................... Alpha-Methylthiofentanyl ................................................................................................................................................. 3-Methylthiofentanyl ......................................................................................................................................................... Furanylfentanyl ................................................................................................................................................................ Thiofentanyl ..................................................................................................................................................................... Beta-Hydroxythiofentanyl ................................................................................................................................................. Para-Methoxybutyryl Fetnanyl ......................................................................................................................................... Ocfentanil ......................................................................................................................................................................... Valeryl Fentanyl ............................................................................................................................................................... Tetrahydrofuranyl Fentanyl .............................................................................................................................................. Crotonyl Fentanyl ............................................................................................................................................................ Cyclopropyl Fentanyl ....................................................................................................................................................... Cyclopentyl Fentanyl ....................................................................................................................................................... Fentanyl Related Compounds ......................................................................................................................................... Amphetamine ................................................................................................................................................................... Methamphetamine ........................................................................................................................................................... 1-Phenylcyclohexylamine ................................................................................................................................................ PCP ................................................................................................................................................................................. ANPP ............................................................................................................................................................................... Norfentanyl ...................................................................................................................................................................... P2P .................................................................................................................................................................................. PCC ................................................................................................................................................................................. Alphaprodine .................................................................................................................................................................... VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 PO 00000 Frm 00116 Fmt 4703 Sfmt 4703 E:\FR\FM\24FEN1.SGM 24FEN1 7536 7537 7538 7540 7541 7542 7543 7544 7545 7546 7547 7694 8112 8113 9200 9313 9319 9547 9551 9560 9601 9602 9603 9604 9605 9606 9607 9612 9614 9615 9616 9619 9624 9628 9661 9663 9750 9811 9812 9813 9814 9815 9816 9821 9822 9823 9825 9824 9826 9827 9830 9831 9832 9833 9834 9835 9836 9837 9838 9840 9843 9844 9845 9847 9850 1100 1105 7460 7471 8333 8366 8501 8603 9010 Schedule I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I I II II II II II II II II II 11333 Federal Register / Vol. 86, No. 35 / Wednesday, February 24, 2021 / Notices Controlled substance Drug code Anileridine ........................................................................................................................................................................ Diphenoxylate .................................................................................................................................................................. Ecgonine .......................................................................................................................................................................... Levorphanol ..................................................................................................................................................................... Meperidine ....................................................................................................................................................................... Meperidine Intermediate-A .............................................................................................................................................. Meperidine Intermediate-B .............................................................................................................................................. Meperidine Intermediate-C .............................................................................................................................................. Dextropropoxyphene ....................................................................................................................................................... Levo-alphacetylmethadol ................................................................................................................................................. Alfentanil .......................................................................................................................................................................... Remifentanil ..................................................................................................................................................................... Sufentanil ......................................................................................................................................................................... Carfentanil ....................................................................................................................................................................... Tapentadol ....................................................................................................................................................................... Fentanyl ........................................................................................................................................................................... William T. McDermott, Assistant Administrator. 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. [FR Doc. 2021-03758 Filed 2-21; 8:45 am] SUPPLEMENTARY INFORMATION: The company plans to manufacture the above listed controlled substances as analytical reference materials, proficiency test materials and academic research materials for distribution to its customers. No other activities for these drug codes are authorized for this registration. In accordance with 21 CFR 1301.34(a), this is notice that on September 30, 2020, Globyz Pharma, LLC, 2101 Market Street, Suite 5, Upper Chichester, Pennsylvania 19061–4001, applied to be registered as an importer of the following basic class(es) of controlled substance(s): BILLING CODE P DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA–790] Importer of Controlled Substances Application: Globyz Pharma, LLC Drug Enforcement Administration, Justice. ACTION: Notice of application. Controlled substance Drug code Schedule Oxycodone ..................... 9143 II AGENCY: Globyz Pharma, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplemental Information listed below for further drug information. DATES: Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before March 26, 2021. Such persons may also file a written request for a hearing on the application on or before March 26, 2021. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for a hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, khammond on DSKJM1Z7X2PROD with NOTICES SUMMARY: VerDate Sep<11>2014 17:21 Feb 23, 2021 Jkt 253001 The company plans to import the listed controlled substance to complete analytical testing. No other activity for these drug codes is authorized for this registration. Approval of permit applications will occur only when the registrant’s business activity is consistent with what is authorized under 21 U.S.C. 952(a)(2). Authorization will not extend to the import of Food and Drug Administration-approved or nonapproved finished dosage forms for commercial sale. William T. McDermott, Assistant Administrator. [FR Doc. 2021–03834 Filed 2–23–21; 8:45 am] BILLING CODE 4410–09–P PO 00000 Frm 00117 Fmt 4703 Sfmt 4703 9020 9170 9180 9220 9230 9232 9233 9234 9273 9648 9737 9739 9740 9743 9780 9801 Schedule II II II II II II II II II II II II II II II II DEPARTMENT OF LABOR Mine Safety and Health Administration Petitions for Modification of Application of Existing Mandatory Safety Standards Mine Safety and Health Administration, Labor. ACTION: Notice. AGENCY: This notice is a summary of a petition for modification submitted to the Mine Safety and Health Administration (MSHA) by the party listed below. DATES: All comments on the petition must be received by MSHA’s Office of Standards, Regulations, and Variances on or before March 26, 2021. ADDRESSES: You may submit your comments, identified by ‘‘docket number’’ on the subject line, by any of the following methods: 1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket number of the petition in the subject line of the message. 2. Facsimile: 202–693–9441. 3. Regular Mail or Hand Delivery: MSHA, Office of Standards, Regulations, and Variances, 201 12th Street South, Suite 4E401, Arlington, Virginia 22202–5452, Attention: S. Aromie Noe, Acting Deputy Director, Office of Standards, Regulations, and Variances. Persons delivering documents are required to check in at the receptionist’s desk in Suite 4E401. Individuals may inspect copies of the petition and comments during normal business hours at the address listed above. MSHA will consider only comments postmarked by the U.S. Postal Service or proof of delivery from another delivery service such as UPS or Federal Express on or before the deadline for comments. SUMMARY: E:\FR\FM\24FEN1.SGM 24FEN1

Agencies

[Federal Register Volume 86, Number 35 (Wednesday, February 24, 2021)]
[Notices]
[Pages 11330-11333]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-03758]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration

[Docket No. DEA-792]


Bulk Manufacturer of Controlled Substances Application: Synthcon 
LLC

AGENCY: Drug Enforcement Administration, Justice.

ACTION: Notice of application.

-----------------------------------------------------------------------

SUMMARY: Synthcon LLC, has applied to be registered as a bulk 
manufacturer of basic class(es) of controlled substance(s). Refer to 
Supplemental Information listed below for further drug information.

DATES: Registered bulk manufacturers of the affected basic class(es), 
and applicants therefore, may file written comments on or objections to 
the issuance of the proposed registration on or before April 26, 2021. 
Such persons may also file a written request for a hearing on the 
application on or before April 26, 2021.

ADDRESSES: Written comments should be sent to: Drug Enforcement 
Administration, Attention: DEA Federal Register Representative/DPW, 
8701 Morrissette Drive, Springfield, Virginia 22152.

SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this 
is notice that on January 5, 2021, Synthcon LLC., 770 Wooten Road, 
Suite 101, Colorado Springs, Colorado 80915-3538, applied to be 
registered as a bulk

[[Page 11331]]

manufacturer of the following basic class(es) of controlled 
substance(s):

------------------------------------------------------------------------
        Controlled substance            Drug code          Schedule
------------------------------------------------------------------------
3-FMC..............................            1233  I
Cathinone..........................            1235  I
Methcathinone......................            1237  I
4-FMC..............................            1238  I
Pentedrone.........................            1246  I
Mephedrone (4-Methyl-N-                        1248  I
 methylcathinone).
4-MEC..............................            1249  I
Naphyrone..........................            1258  I
N-Ethylamphetamine.................            1475  I
N,N-Dimethylamphetamine............            1480  I
Aminorex...........................            1585  I
Cis-4-Methylaminorex...............            1590  I
GHB................................            2010  I
Methaqualone.......................            2565  I
Mecloqualone.......................            2572  I
JWH-250............................            6250  I
ADB-PINACA.........................            7035  I
JWH-018............................            7118  I
JWH-073............................            7173  I
JWH-200............................            7200  I
JWH-203............................            7203  I
4-Methyl-alpha-                                7245  I
 ethylaminopentiophenone.
N-Ethyhexedrone....................            7246  I
AET................................            7249  I
Ibogaine...........................            7260  I
CP-47,497..........................            7297  I
CP-47,497 C8 HOMOLOG...............            7298  I
LSD................................            7315  I
2C-T-7.............................            7348  I
Tetrahydrocannabinols..............            7370  I
Mescaline..........................            7381  I
2C-T-2.............................            7385  I
3,4,5-TMA..........................            7390  I
DOB................................            7391  I
2CB................................            7392  I
DOM................................            7395  I
2,5-DMA............................            7396  I
JWH-398............................            7398  I
DOE................................            7399  I
MDA................................            7400  I
5-METHOXY-MDA......................            7401  I
N-HYDROXY-MDA......................            7402  I
MDEA...............................            7404  I
MDMA...............................            7405  I
PMA................................            7411  I
5-MeO-DMT..........................            7431  I
AMT................................            7432  I
Bufotenine.........................            7433  I
DET................................            7434  I
DMT................................            7435  I
Psilocybin.........................            7437  I
Psilocin...........................            7438  I
5-Methoxy-N,N-diisopropyltryptamine            7439  I
4-Methyl-alpha-                                7446  I
 pyrrolidinohexiophenone.
PCE................................            7455  I
PCPy...............................            7458  I
TCP................................            7470  I
TCPy...............................            7473  I
JB323..............................            7482  I
JB336..............................            7484  I
BZP................................            7493  I
4-MePPP............................            7498  I
2C-D...............................            7508  I
2C-E...............................            7509  I
2C-H...............................            7517  I
2C-I...............................            7518  I
2C-C...............................            7519  I
2C-N...............................            7521  I
2C-P...............................            7524  I
2C-T-4.............................            7532  I
MDPV...............................            7535  I

[[Page 11332]]

 
25B-NBOME..........................            7536  I
25C-NBOME..........................            7537  I
25I-NBOME..........................            7538  I
Methylone..........................            7540  I
Butylone...........................            7541  I
Pentylone..........................            7542  I
N-Ethylpentyloe....................            7543  I
Alpha-Pyrrolidinohexanophenone.....            7544  I
Alpha-PVP..........................            7545  I
Alpha-PBP..........................            7546  I
Ethylone...........................            7547  I
AM-694.............................            7694  I
Pseudoephedrine....................            8112  I
Ephedrine..........................            8113  I
Heroin.............................            9200  I
Normorphine........................            9313  I
Acetorphine........................            9319  I
U-47700............................            9547  I
AH-7921............................            9551  I
MT-45..............................            9560  I
Acetylmethadol.....................            9601  I
Allylprodine.......................            9602  I
Alphacetylmethadol.................            9603  I
Alphameprodine.....................            9604  I
Alphamethadol......................            9605  I
Benzethidine.......................            9606  I
Betacetylmethadol..................            9607  I
Clonitazine........................            9612  I
Isontonitazene.....................            9614  I
Diampromide........................            9615  I
Diethylthiambutene.................            9616  I
Dimethylthiambutene................            9619  I
Etonitazene........................            9624  I
Ketobemidone.......................            9628  I
MPPP...............................            9661  I
PEPAP..............................            9663  I
Tilidine...........................            9750  I
Acryl Fentanyl.....................            9811  I
Para-fluorofentanyl................            9812  I
3-Methylfentanyl...................            9813  I
Alpha-methylfentanyl...............            9814  I
Acetyl-alpha-methylfentanyl........            9815  I
Ortho-fluorofentanyl...............            9816  I
Acetylfentanyl.....................            9821  I
Butyrylfentanyl....................            9822  I
Para-fluorofentanyl................            9823  I
Methoxyacetyl fentanyl.............            9825  I
4-Fluoroisobutyryl fentanyl (N-(4-             9824  I
 fluorophenyl)-N-(1-
 phenethylpiperidin-4-
 yl)isobutyramide).
Para-chloroisobutyryl fentanyl.....            9826  I
Isobutyrylfentanyl.................            9827  I
Beta-Hydroxyfentanyl...............            9830  I
Beta-Hydroxy-3-methylfentanyl......            9831  I
Alpha-Methylthiofentanyl...........            9832  I
3-Methylthiofentanyl...............            9833  I
Furanylfentanyl....................            9834  I
Thiofentanyl.......................            9835  I
Beta-Hydroxythiofentanyl...........            9836  I
Para-Methoxybutyryl Fetnanyl.......            9837  I
Ocfentanil.........................            9838  I
Valeryl Fentanyl...................            9840  I
Tetrahydrofuranyl Fentanyl.........            9843  I
Crotonyl Fentanyl..................            9844  I
Cyclopropyl Fentanyl...............            9845  I
Cyclopentyl Fentanyl...............            9847  I
Fentanyl Related Compounds.........            9850  I
Amphetamine........................            1100  II
Methamphetamine....................            1105  II
1-Phenylcyclohexylamine............            7460  II
PCP................................            7471  II
ANPP...............................            8333  II
Norfentanyl........................            8366  II
P2P................................            8501  II
PCC................................            8603  II
Alphaprodine.......................            9010  II

[[Page 11333]]

 
Anileridine........................            9020  II
Diphenoxylate......................            9170  II
Ecgonine...........................            9180  II
Levorphanol........................            9220  II
Meperidine.........................            9230  II
Meperidine Intermediate-A..........            9232  II
Meperidine Intermediate-B..........            9233  II
Meperidine Intermediate-C..........            9234  II
Dextropropoxyphene.................            9273  II
Levo-alphacetylmethadol............            9648  II
Alfentanil.........................            9737  II
Remifentanil.......................            9739  II
Sufentanil.........................            9740  II
Carfentanil........................            9743  II
Tapentadol.........................            9780  II
Fentanyl...........................            9801  II
------------------------------------------------------------------------

    The company plans to manufacture the above listed controlled 
substances as analytical reference materials, proficiency test 
materials and academic research materials for distribution to its 
customers. No other activities for these drug codes are authorized for 
this registration.

William T. McDermott,
Assistant Administrator.
[FR Doc. 2021-03758 Filed 2-21; 8:45 am]
BILLING CODE P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.